Donna S. Boston led programs for over three decades with the U.S. Government, meeting mission requirements and fielding successful FDA-approved products. Her expertise in designing, developing, validating and procuring health security products and technologies allowed them to emerge from the development pipeline and reach the clinical market to protect the health and well-being of the population.
During her years with the public health emergency and chemical and biological defense programs, Donna evaluated scores of technologies for their readiness to become part of the USG portfolio of medical countermeasures, and promoted their advanced development, FDA-approval, commercialization, stockpiling and distribution.
In 2018 she co-launched the BARDA DRIVe program to address gaps in preparedness and areas within the continuum of public health response that require innovative and entrepreneurial approaches.
And in support of the pandemic task force's Operation Warp Speed in 2020, her programs resulted in the delivery of much-needed validated diagnostic tests for COVID-19 in unprecedented speed, with FDA-authorized COVID-19 test kits that began shipping to labs across the U.S. within weeks of their development.